ATI RN
ATI RN Pharmacology 2023 II Questions
Extract:
Question 1 of 5
A nurse is providing teaching to a client who has a new prescription for carbamazepine for the treatment of seizures. The nurse should instruct the client to monitor for which of the following adverse effects?
Correct Answer: A
Rationale: The correct answer is A: Blurred vision. Carbamazepine is known to cause ocular side effects, including blurred vision. The rationale behind this is that carbamazepine can affect the eye muscles and nerves, leading to visual disturbances. It is important for the client to monitor for any changes in vision and report them to their healthcare provider.
Other choices (B, C,
D) are incorrect because tachypnea (fast breathing), insomnia, and metallic taste are not common adverse effects associated with carbamazepine use. It is crucial for the nurse to focus on educating the client about the specific potential adverse effects of the medication to ensure early detection and appropriate management.
Question 2 of 5
A nurse is caring for a client who has a gonococcal infection and has been prescribed an IM injection of ceftriaxone. The client refuses the medication because they are afraid of needles. Which of the following responses should the nurse make?
Correct Answer: B
Rationale: The correct response is B: "I will discuss other treatment options with your provider." This answer is appropriate because it shows the nurse's willingness to address the client's fear of needles and explore alternative treatments. It demonstrates patient-centered care and promotes open communication. Option A may minimize the client's fear but doesn't address the underlying issue. Option C is coercive and does not respect the client's autonomy. Option D uses fear tactics and is not therapeutic.
Question 3 of 5
A nurse is caring for a client who has cirrhosis of the liver and is receiving spironolactone. Which of the following findings indicates that the client is responding to the treatment?
Correct Answer: D
Rationale: The correct answer is D: Decreased ascites. Spironolactone is a diuretic commonly used in cirrhosis to reduce fluid retention, specifically ascites. As the medication helps the body eliminate excess fluid, a decrease in ascites would indicate that the client is responding to the treatment. Increased appetite (
A) and increased energy (
C) are not directly related to the medication or the treatment of cirrhosis. Decreased jaundice (
B) is more indicative of improved liver function rather than the specific response to spironolactone.
Question 4 of 5
A nurse is caring for a client who is experiencing severe vomiting. Which of the following medications should the nurse plan to administer?
Correct Answer: B
Rationale: The correct answer is B: Prochlorperazine. Prochlorperazine is an antiemetic medication used to treat severe vomiting. It works by blocking dopamine receptors in the brain, helping to relieve nausea and vomiting. Propafenone (
A) is an antiarrhythmic medication, not indicated for vomiting. Metformin (
C) is used to treat diabetes, not vomiting. Simvastatin (
D) is a statin medication used to lower cholesterol, not for vomiting. In this scenario, the nurse should administer Prochlorperazine to help alleviate the client's severe vomiting.
Question 5 of 5
A nurse is caring for a client who is receiving high-dose metoclopramide. The nurse should monitor the client for which of the following adverse effects?
Correct Answer: D
Rationale: The correct answer is D: Tardive dyskinesia. Metoclopramide is associated with this adverse effect, characterized by involuntary movements of the face, tongue, and extremities. The nurse should monitor for signs such as lip smacking, tongue protrusion, and rapid eye movements. Oral candidiasis (
A) is not directly related to metoclopramide. Black stools (
B) could indicate gastrointestinal bleeding but is not a common adverse effect of metoclopramide. Dry cough (
C) is not a typical side effect.
Therefore, the nurse should focus on monitoring for tardive dyskinesia (
D) when administering high-dose metoclopramide.